{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T06:11:36Z","timestamp":1697436696859},"reference-count":28,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,11,3]],"date-time":"2008-11-03T00:00:00Z","timestamp":1225670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Paediatrica"],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Aim: The aim of this study was to document the epidemiology, microbiology and outcome of invasive pneumococcal disease (IPD) among children &lt;16 years with quality surveillance data, just prior to the introduction of the heptavalent pneumococcal conjugate vaccine (PCV7) into the Danish routine immunization programme October 2007.<\/jats:p><jats:p>Methods: Clinical and microbiological records on cases of IPD in children &lt;16 years admitted to Hvidovre Hospital, Denmark 1996\u20132007, were retrospectively reviewed.<\/jats:p><jats:p>Results: We identified 106 cases of IPD. The annual incidence of IPD was 11 per 100 000 in children &lt;16 years, but considerably higher, 62 per 100 000, in children &lt;2 years. Additionally, of the children with pneumococcal meningitis 86% were &lt;2 years. We observed no fatalities. A total of 10% developed sequelae, but of the patients with pneumococcal meningitis 27% developed sequelae. Nine patients had known risk factors. The <jats:italic>Streptococcus pneumoniae<\/jats:italic> serotype was available for 81 cases. Seventy\u2010five percent of the IPD cases in children aged &lt;2 years were caused by one of the serotypes contained within PCV7, compared to only 24% in children \u22652 years.<\/jats:p><jats:p>Conclusion: Our data indicate that an estimated 75% of all IPD cases among children &lt;2 years are caused by PCV7 serotypes and might therefore be prevented by PCV7 vaccination.<\/jats:p>","DOI":"10.1111\/j.1651-2227.2008.01080.x","type":"journal-article","created":{"date-parts":[[2008,12,3]],"date-time":"2008-12-03T19:12:41Z","timestamp":1228331561000},"page":"328-331","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Invasive pneumococcal disease in Danish children, 1996\u20132007, prior to the introduction of heptavalent pneumococcal conjugate vaccine"],"prefix":"10.1111","volume":"98","author":[{"given":"Thilde N","family":"Winther","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim D","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margit S","family":"Kaltoft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helle B","family":"Konradsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny D","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birthe","family":"H\u00f8gh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,1,12]]},"reference":[{"key":"e_1_2_7_2_2","article-title":"Purulent meningitis 2006","volume":"45","author":"Howitz M","year":"2007","journal-title":"EPI-NEWS"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365540110080403"},{"key":"e_1_2_7_4_2","first-page":"93","article-title":"Pneumococcal vaccines","volume":"82","author":"WHO position paper","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(06)70520-5"},{"issue":"9","key":"e_1_2_7_6_2","first-page":"1","article-title":"Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Reports","volume":"49","author":"ACIP","year":"2000","journal-title":"Recommended Rep"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.106.2.362"},{"key":"e_1_2_7_8_2","first-page":"893","article-title":"Direct and indirect effects of routine vaccination of children with 7\u2010valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease\u2014United States, 1998\u20132003","volume":"54","author":"Centers for Disease Control and Prevention (CDC)","year":"2005","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00807-1"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.14.1668"},{"key":"e_1_2_7_11_2","article-title":"Pneumococcal vaccination of at\u2010risk children","volume":"11","author":"Andersen PH","year":"2007","journal-title":"EPI-NEWS"},{"key":"e_1_2_7_12_2","article-title":"Pneumococcal disease in the childhood vaccination programme","volume":"37","author":"Valentiner\u2010Branth P","year":"2007","journal-title":"EPI-NEWS"},{"key":"e_1_2_7_13_2","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1128\/jcm.31.8.2097-2100.1993","article-title":"Typing of pneumococci by using 12 pooled antisera","volume":"31","author":"Sorensen UB","year":"1993","journal-title":"J Clin Microbiol"},{"key":"e_1_2_7_14_2","unstructured":"The Swedish Reference Group for Antibiotics.The Swedish Association of Medicine the Swedish Institute for Infectious Disease Control and the Swedish strategic programme against antibiotic resistance. Available at:http:\/\/www.srga.org\/."},{"key":"e_1_2_7_15_2","first-page":"1","article-title":"Epidemiology of invasive pneumococcal infections in children aged 0\u20136 years in Denmark: a 19\u2010year nationwide surveillance study","volume":"435","author":"Kaltoft MS","year":"2000","journal-title":"Acta Paediatr Suppl"},{"key":"e_1_2_7_16_2","first-page":"358","article-title":"Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance","volume":"9","author":"Konradsen HB","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.47690-0"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365540110026818"},{"key":"e_1_2_7_19_2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF03403742","article-title":"Epidemiology of invasive pneumococcal disease in BC during the introduction of conjugated pneumococcal vaccine","volume":"99","author":"Winters M","year":"2008","journal-title":"Can J Public Health"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1086\/587897"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.102.5.1087"},{"key":"e_1_2_7_22_2","first-page":"129","article-title":"Pneumococcal meningitis and bacteraemia in Danish children 1969\u20131978. Serotypes, incidence and outcome","volume":"91","author":"Pedersen FK","year":"1983","journal-title":"Acta Pathol Microbiol Immunol Scand [B]"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0204.9604"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31805cdbeb"},{"key":"e_1_2_7_25_2","first-page":"301","article-title":"Streptococcus pneumoniae serogroups 15 and 33. An increasing cause of pneumococcal infections in children in United States after the introduction of pneumococcal 7\u2010valent conjugate vaccine","volume":"25","author":"Gonzales BE","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"e_1_2_7_26_2","unstructured":"O'BrienKL WeatherholtzR MillarEV.Replacement invasive pneumococcal disease 9 years after introduction of PCV among a population at high risk of IPD: The Navajo Experience. In:Program and Abstracts of the 5th International Symposium on Pneumococci and Pneumococcal Diseases; April 2\u20136 2006; Alice Springs Australia Abstract P04.17:189."},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-8-81"},{"key":"e_1_2_7_28_2","unstructured":"DANMAP.Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals and humans in Denmark. ISSN 1600\u20103032 2006. Available at:http:\/\/www.danmap.org\/."},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200003000-00003"}],"container-title":["Acta Paediatrica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1651-2227.2008.01080.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1651-2227.2008.01080.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T18:45:13Z","timestamp":1697395513000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1651-2227.2008.01080.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,12]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1111\/j.1651-2227.2008.01080.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1651-2227.2008.01080.x","archive":["Portico"],"relation":{},"ISSN":["0803-5253","1651-2227"],"issn-type":[{"value":"0803-5253","type":"print"},{"value":"1651-2227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,12]]},"assertion":[{"value":"2009-01-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}